MDT — Medtronic Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual income statement for Medtronic, fiscal year end - April 25th, USD millions except per share, conversion factor applied.

	2021 April 30th	2022 April 29th	2023 April 28th	2024 April 26th	2025 April 25th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	8-K
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	30,117	31,686	31,227	32,364	33,537
Cost of Revenue
Gross Profit	19,762	21,715	20,605	21,273	22,007
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	25,941	25,934	25,795	27,220	27,582
Operating Profit	4,176	5,752	5,432	5,144	5,955
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,895	5,517	5,364	4,837	5,628
Provision for Income Taxes
Net Income After Taxes	3,524	5,061	3,784	3,704	4,692
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	3,606	5,039	3,758	3,676	4,663
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	3,606	5,039	3,758	3,676	4,662
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.56	4.59	2.94	3.95	4.16
Dividends per Share